DECNUPAZ

Product NDC: 0074-0282
11-digit product format: 000740282
Labeler code: 0074
Product ID: 0074-0282_a7f31acd-4120-420a-ab5d-10415866e41a
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: pivekimab sunirine-pvzy
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Labeler: AbbVie Inc.
Application: BLA761460
Marketing category: BLA
Marketing start: 2026-05-27
Substance: PIVEKIMAB SUNIRINE
Active strength: 2 mg/mL
Listing certified through: 2027-12-31
Current FDA listing: Yes

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DECNUPAZ	PIVEKIMAB SUNIRINE-PVZY	AbbVie Inc.	508b6ff8-601d-4901-a7a5-816141134054	2026-05-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: BLA761460 ndc (product): 0074-0282

Additional Listing Data#

Finished product: Yes
Brand name base: DECNUPAZ
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
PIVEKIMAB SUNIRINE	2 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
L15LO3W1XX	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2744303	Internal RxNorm lookup
2744309	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
508b6ff8-601d-4901-a7a5-816141134054	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761460	Decnupaz	pivekimab sunirine-pvzy	351(a)	Rx	2026-06-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Status
0074-0282-02	00074028202	1 VIAL, SINGLE-DOSE in 1 CARTON (0074-0282-02) / 1.15 mL in 1 VIAL, SINGLE-DOSE	2026-05-27	0	Current